ENCBS835VCD / in vitro differentiated cells
Summary
- Status
- released
- Term name
- hematopoietic multipotent progenitor cell
- Term ID
- CL:0000837
- Summary
- Homo sapiens male adult (25 years) hematopoietic multipotent progenitor in vitro differentiated cells treated with interleukin-3 for 13 days, kit ligand for 13 days, hydrocortisone succinate for 13 days, erythropoietin for 13 days
- Description
- Day 13 (T13)
Attribution
ENCODE3 project
- Lab
- John Stamatoyannopoulos, UW
- Award PI
- John Stamatoyannopoulos, UW
- Submitted by
- Michael Buckley
- Source
- Shelly Heimfeld
- Project
- ENCODE
- External resources
- Aliases
- john-stamatoyannopoulos:DS25851A
Treatment details
- Treatment
- interleukin-3 (UniProtKB:P08700) for 13 days
- Type
- protein
- Purpose
- stimulation
- Treatment
- kit ligand (UniProtKB:P21583) for 13 days
- Type
- protein
- Purpose
- stimulation
- Treatment
- hydrocortisone succinate (CHEBI:31677) for 13 days
- Type
- chemical
- Purpose
- stimulation
- Treatment
- erythropoietin (CHEBI:81579) for 13 days
- Type
- chemical
- Purpose
- stimulation
Donor information
- Status
- released
- Accession
- ENCDO937OUY
- Aliases
- encode:donor of RO 02366, roadmap-epigenomics:RO 02366, john-stamatoyannopoulos:RO_02366
- Species
- Homo sapiens
- Life stage
- adult
- Age
- 25 years
- Sex
- male
- External resources
Documents
treatment protocol
Description: Erythroid differentiation of human CD34+ cells
- Submitted by
- Jason Hilton
- Lab
- John Stamatoyannopoulos, UW
- Grant
- U54HG007010
cell isolation protocol
Description: Isolation of CD34-positive cells from human leukapheresis product
- Submitted by
- Michael Buckley
- Lab
- John Stamatoyannopoulos, UW
- Grant
- U54HG007010